ArticleChina CDC weekly2026
Epidemiological Characteristics of Anthrax and
Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The incidence of anthrax in China has declined since 1990 but has resurged in recent years. The purpose of this study was to describe the epidemiology of anthrax and Methods: A descriptive analysis was performed of case characteristics. Results: Between 2020 and 2024, 1,870 anthrax cases were reported, with a 0.59% case fatality rate. The majority of cases were cutaneous and the incidence increased from year to year. Cases were distributed across 12 provincial-level administrative divisions (PLADs), with most regions showing an increased incidence between 2021 and 2024. Farmers and herders were the most affected occupational groups, and farmers accounted for an increasing proportion of cases. Cases were primarily concentrated among young and middle-aged men and peaked between July and September. A total of 185 Conclusions: From 2020 to 2024, anthrax cases generally followed historical patterns but the incidence increased, with broader geographical spread, more diverse clinical types, and interprovincial transmission. These findings highlight the need to strengthen anthrax control efforts, particularly in the central and eastern PLADs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.